Buy Crypto
Pay with
USD
USD
Buy & Sell
Hot
Supports Visa, Mastercard, SEPA & more
P2P
0 Fees
Flexible trading, zero fees
Gate Card
Use your crypto for payments worldwide
Markets
Trade
Basic
Advanced
Futures
Futures
Access hundreds of perpetual contracts
CFD
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Stocks
CFD
Stock CFD Derivatives
US Stocks
Access real US stocks and ETFs
HK Stocks
Trade quality Hong Kong-listed stocks
Korean Stocks
SK Hynix
Real Korean stocks and top assets
Stock Futures
High leverage, 24/7 trading
Tokenized Stocks
Backed by real stock assets
IPO Access
Unlock full access to global stock IPOs
GUSD
3.8%
Mint GUSD for Treasury RWA yields
Stocks Activities
Trade Popular Stocks and Unlock Generous Airdrops
Earn
Launch
CandyDrop
tag
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Investment
Square
Square
Post, share, and explore crypto trends
Live
moments live
Live crypto market analysis
Chat
Chat with crypto traders
News
What is happening in crypto
flower_head
More
Promotions
AI
Others
IPO
2026 World Cup
Rewards

Zhenjianankang Medical Stock Hits HK$500 on July 13, Up Nearly 3x From IPO Price

GateNews
Stocks
According to Zhitong Finance, Zhenjianankang Medical (02697) stock hit HK$500 during intraday trading on July 13, rising nearly 3x from its IPO price, with market capitalization briefly exceeding HK$17.1 billion. The company achieved a fundraising subscription multiple of 682.43x during its IPO and surged 216.96% on its first trading day, with an IPO market cap of HK$14.26 billion. In 2025, the company delivered six surgical robotic systems and generated revenue of HK$12.178 million, compared to HK$1.791 million in 2024, with gross margin reaching 76.3%. According to Zhizu Consulting, the company held a 36.4% market share by unit volume and 28.0% by revenue in China's percutaneous puncture surgical robot market in 2025, ranking first nationwide.
View Source
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.

Related News

3h ago
Hang Seng Index Up 56 Points at Midday; Chinese Banking Stocks Rally
07-11 11:55
Hanshing Corporation Stock Surges 114.4% to 8,460 Won in 10 Trading Days, Market Cap Doubles to 525 Billion Won
07-10 06:51
Zhipu Market Cap Holds 906 Billion HKD While MiniMax Tumbles to 93.3 Billion on Share Unlock July 8-9
07-10 04:06
Hong Kong Stocks Rally: Hang Seng Index Up 1.86%, Biotech Subindex Surges 5.77% on Drug Policy Update
07-10 01:31
Jing He Integrated Circuits (02249) Debuts on HK Exchange at HK$32.3, Up 11.46% on Day One
In-Depth Analysis

Hong Kong Stocks Turn Negative as Hang Seng Index Faces Selling Pressure at 24500

Lucas Bennett5h ago

SpaceX Stocks: LS Securities Analyst Highlights StarMind Orbital Data Center Strategy

Lucas Bennett6h ago

SK hynix shares listed on Nasdaq, with $26.5 billion in ADR setting a new record

Market Whisper6h ago
Comment
0/400
No comments